Titel	Veröffentlichungsdatum	Sprache	Zitate
Prognostic and Predictive Factors in Early-Stage Breast Cancer	2004/11/01	English	375
Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects	2011/01/01	English	375
Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor	2015/05/22	English	373
Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer	2013/02/01	English	371
The Oncosurgery Approach to Managing Liver Metastases from Colorectal Cancer: A Multidisciplinary International Consensus	2012/09/07	English	364
Interferon in Oncological Practice: Review of Interferon Biology, Clinical Applications, and Toxicities	2001/02/01	English	339
Chemotherapeutic Approaches for Targeting Cell Death Pathways	2006/04/01	English	337
VEGF Receptor Signaling in Tumor Angiogenesis	2000/04/01	English	335
Why the Epidermal Growth Factor Receptor? The Rationale for Cancer Therapy	2002/08/15	English	329
Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Sorafenib: A Review of Four Phase I Trials in Patients with Advanced Refractory Solid Tumors	2007/04/01	English	324
FDA Drug Approval Summary: Azacitidine (5-azacytidine, Vidaza™) for Injectable Suspension	2005/03/01	English	317
New Routes to Targeted Therapy of Intrahepatic Cholangiocarcinomas Revealed by Next-Generation Sequencing	2014/02/21	English	315
Management and Preparedness for Infusion and Hypersensitivity Reactions	2007/05/01	English	312
Distance as a Barrier to Cancer Diagnosis and Treatment: Review of the Literature	2015/10/28	English	311
Hepatotoxicity of Chemotherapy	2001/04/01	English	309
Ewing's Sarcoma Family of Tumors: Current Management	2006/05/01	English	306
Epidermal Growth Factor Receptor Dependence in Human Tumors: More Than Just Expression?	2002/08/15	English	304
FDA Drug Approval Summary: Erlotinib (Tarceva®) Tablets	2005/08/01	English	298
Cancer Survival and Incidence from the Surveillance, Epidemiology, and End Results (SEER) Program	2003/12/01	English	294
Expanding Criteria for Resectability of Colorectal Liver Metastases	2008/01/01	English	288
Amifostine: The First Selective-Target and Broad-Spectrum Radioprotector	2007/06/01	English	287
FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy	2016/03/16	English	287
Primary Vitreoretinal Lymphoma: A Report from an International Primary Central Nervous System Lymphoma Collaborative Group Symposium	2011/11/01	English	285
FDA Drug Approval Summary: Bevacizumab (Avastin®) Plus Carboplatin and Paclitaxel as First-Line Treatment of Advanced/Metastatic Recurrent Nonsquamous Non-Small Cell Lung Cancer	2007/06/01	English	283
Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis	2016/04/06	English	282
Clinical Studies of Three Oral Prodrugs of 5-Fluorouracil (Capecitabine, UFT, S-1): A Review	2002/08/01	English	281
Bisphosphonates: Preclinical Review	2004/09/01	English	281
Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update	2019/06/19	English	279
Bisphosphonates: Clinical Experience	2004/09/01	English	269
Phase II and Pharmacodynamic Study of Autophagy Inhibition Using Hydroxychloroquine in Patients With Metastatic Pancreatic Adenocarcinoma	2014/05/12	English	258